New hybrid rehab could help PAD patients walk farther and protect their hearts
NCT ID NCT03649204
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a hybrid rehabilitation program for people with peripheral arterial disease (PAD), a condition that causes leg pain and limits walking. The program combines a few on-site supervised sessions with a home-based walking plan to make it easier for patients to participate. Researchers measured changes in walking distance, quality of life, and heart risk after 3 months in 26 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hybrid rehabilitation program (on-site and home-based walking exercise)
What this could lead to
If successful, this hybrid program could offer a flexible, effective way for people with PAD to improve their walking ability and reduce heart disease risk.
What could go wrong
This is a very small pilot study with only 26 participants, so results may not apply to everyone. The program's success depends on patient commitment and may not work for all.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada